Biomed firms keen to set up at Biopolis Phase III
Wednesday • April 9, 2008
Tan Hui Leng
huileng@mediacorp.com.sg
It just broke ground last Wednesday, but the developer of Biopolis Phase III is already in talks with four interested tenants.
The biomedical companies — two of which are foreign firms — may take up large space and occupy entire floors of the 41,500-square-metres facility.
"We are encouraged by the response," a Crescendas Bionix spokesperson told Today.
The company is the first privately-owned Singapore company to clinch a major development project involving the Biopolis.
The $100-million facility is expected to be completed in the last quarter of next year. The developer hopes to achieve a take-up rate of at least 50 per cent by mid-June.
The two buildings in Phase III will comprise laboratories, research facilities, offices and retail operations. They will also share two interconnecting basement levels.
Singapore's biomedical scene has been active in the last seven years and the biomedical sciences industry now accounts for 6 per cent of Singapore's GDP, up from over 2.5 per cent in 2000.
BMS manufacturing output has also increased by almost four-fold from $6.3 billion in 2000 to $23 billion in 2006, which is 10 per cent of the total manufacturing output in Singapore.
Response to floor space at Biopolis has thus been good with the total 222,000 sq m of floor space in Phase I and II fully taken up. Rental rates for the Phase III complex have not been finalised.
Copyright MediaCorp Press Ltd. All rights reserved.
Singapore Real Estate and Property updates
EastLiving.com.sg
Contact Stuart Chng: (65) 9691 9907
Email: stuart.chng@eastliving.com.sg
EastLiving - Singapore Property and Real Estate DB
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment